Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Guardant Health contributed to performance in the second quarter following a string of positive developments, as several catalysts played out during the quarter. These developments include...
— Mr. Fitzpatrick
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Guardant Health, Inc.
No other institutional pitches found for this ticker yet.
More institutional theses from Aristotle Core Equity Fund
Chart Industries posted positive performance as preliminary 2025 outlooks indicated robust 39% earnings growth despite a Q3 quarterly miss. Management reiterated solid...
The fund established a long position in CrowdStrike to capture secular growth in enterprise cloud migration and security spending. The company's unified...
Aristotle initiated a position in GE Aerospace, citing its dominant position in high-barrier commercial engine manufacturing and long OEM order backlogs. Following significant corporate...